Asklepion Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Asklepion Pharmaceuticals Ownership

Who owns Asklepion Pharmaceuticals?

.

Asklepion Pharmaceuticals Business Overview

Where is Asklepion Pharmaceuticals headquartered?

Asklepion Pharmaceuticals is headquartered in Baltimore, Maryland.

What sector is Asklepion Pharmaceuticals in?

Asklepion Pharmaceuticals is a life science company.

When was Asklepion Pharmaceuticals founded?

Asklepion Pharmaceuticals was founded in 2006.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Asklepion Pharmaceuticals LLC

729 East Pratt Street Suite 360,
Baltimore, Maryland 21202
United States,
(410) 545-0494
www.asklepionpharm.com

Asklepion Pharmaceuticals LLC is a biopharmaceutical company, focus on the development of treatments for rare pediatric diseases. Asklepion strives to channel the powers of science and biotechnology into therapies that are life-saving and to significantly improve the quality of life for sick children and anxious parents.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.0/yr) # 1 - - - - - 1
  1

Most Recent M&A

Company Date Value Type
Asklepion - Liquid Formulation Of Ursodeoxycholic Acid 2016-06-20 - Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science - - 1 (100%) -
Total - - 1 -

By Geo

State/Country Buy Value Sell Value
United States - - 1 -
Total - - 1 -

M&A Connections

Deals
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.